Description

Gliucofaj Coated Tablets 850 mg. №30

Ingredients:

Each coated tablet contains 850 mg of Metformin Hydrochloride.

Mechanism of Action:

Metformin works by decreasing hepatic glucose production and increasing insulin sensitivity, leading to lower blood glucose levels.

Pharmacological Properties:

Metformin belongs to the biguanide class of antidiabetic medications. It reduces hyperglycemia without causing hypoglycemia and promotes weight loss in patients with type 2 diabetes.

Indications for Use:

Gliucofaj coated tablets are indicated for the treatment of type 2 diabetes mellitus to control blood sugar levels and prevent diabetes-related complications.

Contraindications:

Avoid using Gliucofaj tablets if you have severe kidney disease, metabolic acidosis, or a history of lactic acidosis. Consult a healthcare provider before initiating treatment.

Side Effects:

Common side effects may include gastrointestinal disturbances such as diarrhea, nausea, and abdominal discomfort. In rare cases, lactic acidosis can occur, especially in individuals with predisposing factors.

Usage Instructions:

Take one tablet orally with meals once or twice daily, as prescribed by a healthcare provider. Swallow the tablet whole with water; do not crush or chew it.

Benefits Compared to Analogues:

Gliucofaj’s controlled-release formulation offers improved tolerability and reduced gastrointestinal side effects compared to immediate-release metformin products.

Suitable Patient Groups:

Gliucofaj tablets are suitable for adult patients with type 2 diabetes. Dosage adjustments may be necessary for elderly individuals or those with renal impairment.

Storage and Shelf Life:

Store Gliucofaj tablets in a cool, dry place away from moisture and sunlight. Check the expiration date on the packaging and do not use expired medication.

Packaging Description:

Gliucofaj tablets are supplied in a package containing 30 coated tablets of 850 mg each.

Scientific Evidence:

Studies have demonstrated the efficacy of Metformin in improving glycemic control and reducing cardiovascular risk factors in patients with type 2 diabetes. Research published in the Journal of Clinical Investigation supports the beneficial effects of Metformin on glucose metabolism.

Clinical Evidence and Proven Effectiveness:

Clinical studies have shown that Metformin, the active ingredient in Gliucofaj tablets, effectively lowers blood glucose levels and improves insulin sensitivity in patients with type 2 diabetes.

Additional Information:

Regular monitoring of kidney function is essential during treatment with Metformin, as it can impact renal function. Consult a healthcare provider for personalized advice on Gliucofaj tablet use, including potential drug interactions and side effects.